VR
ATYR

Vision Retirement’s aTyr Pharma ATYR Stock Holding History

Vision Retirement’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$895 Hold
1,500
– – ﹤0.01% 592
2026
Q1 		$1.17K Hold
1,500
– – ﹤0.01% 588
2025
Q4 		$1.18K Buy
+1,500
New +$1.23K ﹤0.01% 557

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $140M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vision Retirement's ATYR Position: Q2 2026 in Review

Vision Retirement held its aTyr Pharma (ATYR) position steady in Q2 2026 at 1,500 shares worth $895. The position accounts for ﹤0.01% of the portfolio, ranked #592.

Vision Retirement first reported a position in ATYR in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.18K in Q4 2025. 86 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Vision Retirement held 1,500 shares of aTyr Pharma worth $895 as of Q2 2026.
  • Vision Retirement left its aTyr Pharma share count unchanged in Q2 2026.
  • aTyr Pharma made up ﹤0.01% of Vision Retirement's portfolio in Q2 2026, its #592 holding.
  • Vision Retirement first reported a position in aTyr Pharma in Q4 2025 and has held it in 3 quarters since.
  • Vision Retirement's aTyr Pharma position peaked at $1.18K in Q4 2025.
  • 86 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Vision Retirement's 13F filing for Q2 2026, filed 21 Jul 2026.